Alnylam Initiates Rolling Submission Of NDA For Patisiran To FDA - Quick Facts

Alnylam Pharmaceuticals Inc. (ALNY) said it has initiated submission of a rolling New Drug Application or NDA to the U.S. Food and Drug Administration for Patisiran.

from RTT - Biotech http://ift.tt/2jvD9jg
via IFTTT